EP3280729
CD20 THERAPIES, CD22 THERAPIES, AND COMBINATION THERAPIES WITH A CD19 CHIMERIC ANTIGEN RECEPTOR (CAR) - EXPRESSING CELL
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
8.4.2016EP published:
27.4.2022EP application number:
16719611.2
EPO information:
European Patent Register
Max expiry date:
7.4.2036
Title in English:
CD20 THERAPIES, CD22 THERAPIES, AND COMBINATION THERAPIES WITH A CD19 CHIMERIC ANTIGEN RECEPTOR (CAR) - EXPRESSING CELLLanguage of the patent:
English
Timeline
Today
8.4.2016EP application
27.4.2022EP Publication
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056 Basel, CH
Name:
The Trustees of The University of PennsylvaniaAddress:
3160 Chestnut Street Suite 200, Philadelphia, PA 19104, US
Inventor
Name:
BITTER, HansAddress:
Lincoln, MA 01773, US
Name:
BORDEAUX, Jennifer, MaryAddress:
Carlsbad, CA 92008, US
Name:
BRANNETTI, BarbaraAddress:
4056 Basel, CH
Name:
BROGDON, JenniferAddress:
Cambridge, MA 02139, US
Name:
DAKAPPAGARI, Naveen, KumarAddress:
Carlsbad, CA 92008, US
Name:
GILL, SaarAddress:
Philadelphia, PA 19106, US
Name:
HIGHFILL, StevenAddress:
Bethesda, MD 20814, US
Name:
HUANG, LuAddress:
Cambridge, MA 02139, US
Name:
JUNE, Carl, H.Address:
Merion Station, PA 19066, US
Name:
KIM, Ju, YoungAddress:
Carlsbad, CA 92008, US
Name:
LEI, MingAddress:
Cambridge, MA 02139, US
Name:
LI, NaAddress:
Cambridge, MA 02139, US
Name:
LOEW, AndreasAddress:
Somerville, MA 02143, US
Name:
ORLANDO, ElenaAddress:
Somerville, MA 02143, US
Name:
RUELLA, MarcoAddress:
PA 19143, US
Name:
TRAN, ThaiAddress:
Carlsbad, CA 92008, US
Name:
ZHANG, JiminAddress:
Cambridge, MA 02139, US
Name:
ZHOU, LiAddress:
Cambridge, MA 02139, US
Priority
Number:
201562144639 PDate:
8.4.2015Country:
US
Number:
201562144615 PDate:
8.4.2015Country:
US
Number:
201562144497 PDate:
8.4.2015Country:
US
Number:
201562207255 PDate:
19.8.2015Country:
US
Number:
201562263423 PDate:
4.12.2015Country:
US
Classification
Categories:
C07K 14/725, C07K 16/28, C12N 5/0783, A61K 39/00